AAAAAA
Results:
1-13
|
Results: 13
Authors:
Kroger, LA
DeNardo, GL
Gumerlock, PH
Xiong, CY
Winthrop, MD
Shi, XB
Mack, PC
Leshchinsky, T
DeNardo, SJ
Citation: La. Kroger et al., Apoptosis-related gene and protein expression in human lymphoma xenografts(Raji) after low dose rate radiation using Cu-67-2IT-BAT-Lym-1 radioimmunotherapy, CANC BIO R, 16(3), 2001, pp. 213-225
Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy
Authors:
DeNardo, SJ
Burke, PA
Leigh, BR
O'Donnell, RT
Miers, LA
Kroger, LA
Goodman, SL
Matzku, S
Jonczyk, A
Lamborn, KR
DeNardo, GL
Citation: Sj. Denardo et al., Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy, CANC BIO R, 15(1), 2000, pp. 71-79
Authors:
DeNardo, GL
O'Donnell, RT
Shen, S
Kroger, LA
Yuan, AN
Meares, CF
Kukis, DL
DeNardo, SJ
Citation: Gl. Denardo et al., Radiation dosimetry for Y-90-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using In-111-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma, J NUCL MED, 41(5), 2000, pp. 952-958
Authors:
O'Donnell, RT
Leigh, BR
Christensen, SD
Goldstein, DS
Kukis, DL
Shen, S
Yuan, A
DeNardo, DA
Kroger, LA
Denardo, GL
Citation: Rt. O'Donnell et al., Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associatedlymphoma, CANC BIO R, 14(3), 1999, pp. 167-176
Authors:
Kroger, LA
DeNardo, SJ
DeNardo, GL
Xiong, CY
Winthrop, MD
Gumerlock, PH
Citation: La. Kroger et al., Effect of Cu-67-2IT-BAT-Lym-1 therapy on BCL-2 gene and protein expressionin a lymphoma mouse model, CLIN CANC R, 5(10), 1999, pp. 3010S-3014S
Authors:
DeNardo, SJ
DeNardo, GL
DeNardo, DG
Xiong, CY
Shi, XB
Winthrop, MD
Kroger, LA
Carter, P
Citation: Sj. Denardo et al., Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics, CLIN CANC R, 5(10), 1999, pp. 3213S-3218S
Authors:
DeNardo, GL
O'Donnell, RT
Kroger, LA
Richman, CM
Goldstein, DS
Shen, S
DeNardo, SJ
Citation: Gl. Denardo et al., Strategies for developing effective radioimmunotherapy for solid tumors, CLIN CANC R, 5(10), 1999, pp. 3219S-3223S
Authors:
Richman, CM
DeNardo, SJ
O'Donnell, RT
Goldstein, DS
Shen, S
Kukis, DL
Kroger, LA
Yuan, A
Boniface, GR
Griffith, IJ
DeNardo, GL
Citation: Cm. Richman et al., Dosimetry-based therapy in metastatic breast cancer patients using Y-90 monoclonal antibody 170H.82 with autologous stem cell support and cyclosporina, CLIN CANC R, 5(10), 1999, pp. 3243S-3248S
Authors:
DeNardo, SJ
Kroger, LA
DeNardo, GL
Citation: Sj. Denardo et al., A new era for radiolabeled antibodies in cancer?, CURR OP IM, 11(5), 1999, pp. 563-569
Authors:
DeNardo, GL
O'Donnell, RT
Rose, LM
Mirick, GR
Kroger, LA
DeNardo, SJ
Citation: Gl. Denardo et al., Milestones in the development of Lym-1 therapy, HYBRIDOMA, 18(1), 1999, pp. 1-11
Authors:
DeNardo, SJ
DeNardo, GL
Kukis, DL
Shen, S
Kroger, LA
DeNardo, DA
Goldstein, DS
Mirick, GR
Salako, Q
Mausner, LF
Srivastava, SC
Meares, CE
Citation: Sj. Denardo et al., Cu-67-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma, J NUCL MED, 40(2), 1999, pp. 302-310
Authors:
O'Donnell, RT
DeNardo, SJ
Miers, LA
Kukis, DL
Mirick, GR
Kroger, LA
DeNardo, GL
Citation: Rt. O'Donnell et al., Combined modality radioimmunotherapy with taxol and Y-90-LYM-1 for Raji lymphoma xenografts, CANC BIO R, 13(5), 1998, pp. 351-361
Authors:
Denardo, SJ
Richman, CM
Kukis, DL
Shen, S
Lamborn, KR
Miers, LA
Kroger, LA
Perez, EA
DeNardo, GL
Citation: Sj. Denardo et al., Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: Development of a clinical protocol, ANTICANC R, 18(6A), 1998, pp. 4011-4018
Risultati:
1-13
|